ARKG 01/23/2024

ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.

#DateCompanyTickerCUSIPWeightShares HeldMarket Value
101/23/2024EXACT SCIENCES CORPEXAS30063P1057.90%2,217,680 (0) (0%)$146,389,056.80
201/23/2024CRISPR THERAPEUTICS AGCRSPH171821086.48%1,840,375 (0) (0%)$120,102,872.50
301/23/2024TWIST BIOSCIENCE CORPTWST90184D1005.35%2,852,656 (0) (0%)$99,158,322.56
401/23/2024RECURSION PHARMACEUTICALS-ARXRX75629V1045.17%9,132,032 (871) (0.01%)$95,703,695.36
501/23/2024TELADOC HEALTH INCTDOC87918A1054.57%4,043,159 (0) (0%)$84,663,749.46
601/23/2024PACIFIC BIOSCIENCES OF CALIFPACB69404D1084.46%12,017,431 (0) (0%)$82,679,925.28
701/23/2024IONIS PHARMACEUTICALS INCIONS4622221004.36%1,581,522 (-6,075) (-0.38%)$80,673,437.22
801/23/2024SCHRODINGER INCSDGR80810D1034.11%2,775,922 (0) (0%)$76,032,503.58
901/23/2024ACCOLADE INCACCD00437E1024.01%6,185,624 (0) (0%)$74,289,344.24
1001/23/2024GINKGO BIOWORKS HOLDINGS INCDNA37611X1003.55%53,400,837 (12,903) (0.02%)$65,683,029.51
1101/23/2024ARCTURUS THERAPEUTICS HOLDINARCT UQ03969T1093.43%1,862,885 (0) (0%)$63,598,893.90
1201/23/2024CAREDX INCCDNA14167L1033.42%6,464,636 (0) (0%)$63,418,079.16
1301/23/202410X GENOMICS INC-CLASS ATXG88025U1093.24%1,389,190 (0) (0%)$59,957,440.40
1401/23/2024BEAM THERAPEUTICS INCBEAM07373V1053.16%2,362,294 (0) (0%)$58,490,399.44
1501/23/2024INTELLIA THERAPEUTICS INCNTLA45826J1053.13%2,221,442 (0) (0%)$58,046,279.46
1601/23/2024VERACYTE INCVCYT92337F1072.96%2,079,876 (0) (0%)$54,846,330.12
1701/23/2024ADAPTIVE BIOTECHNOLOGIESADPT00650F1092.67%11,648,268 (0) (0%)$49,388,656.32
1801/23/2024VERTEX PHARMACEUTICALS INCVRTX92532F1002.56%107,928 (0) (0%)$47,500,192.08
1901/23/2024VEEVA SYSTEMS INC-CLASS AVEEV9224751082.33%206,202 (0) (0%)$43,174,574.76
2001/23/2024UIPATH INC – CLASS APATH90364P1052.17%1,714,511 (0) (0%)$40,273,863.39
2101/23/2024VERVE THERAPEUTICS INCVERV92539P1012.09%3,120,790 (0) (0%)$38,666,588.10
2201/23/2024MODERNA INCMRNA60770K1072.01%372,984 (0) (0%)$37,186,504.80
2301/23/2024STANDARD BIOTOOLS INCLAB34385P1081.89%14,374,027 (0) (0%)$34,928,885.61
2401/23/2024908 DEVICES INCMASS65443P1021.75%3,905,000 (0) (0%)$32,372,450.00
2501/23/2024INCYTE CORPINCY45337C1021.61%483,594 (0) (0%)$29,741,031.00
2601/23/2024QUANTUM-SI INCQSI74765K1051.33%14,075,569 (0) (0%)$24,632,245.75
2701/23/2024NURIX THERAPEUTICS INCNRIX67080M1031.25%2,904,008 (0) (0%)$23,115,903.68
2801/23/2024REGENERON PHARMACEUTICALSREGN75886F1071.17%22,973 (0) (0%)$21,659,633.59
2901/23/2024NVIDIA CORPNVDA67066G1041.15%35,564 (0) (0%)$21,215,348.56
3001/23/2024COMPASS PATHWAYS PLCCMPS20451W1011.12%2,382,352 (0) (0%)$20,821,756.48
3101/23/2024REPARE THERAPEUTICS INCRPTX7602731021.00%2,940,592 (299) (0.01%)$18,555,135.52
3201/23/2024PRIME MEDICINE INCPRME74168J1010.98%2,702,440 (0) (0%)$18,106,348.00
3301/23/2024BUTTERFLY NETWORK INCBFLY1241551020.73%12,451,131 (0) (0%)$13,571,732.79
3401/23/2024CERUS CORPCERS1570851010.60%6,215,665 (0) (0%)$11,188,197.00
3501/23/2024PERSONALIS INCPSNL71535D1060.52%5,993,952 (0) (0%)$9,650,262.72
3601/23/2024AMGEN INCAMGN0311621000.51%30,482 (0) (0%)$9,454,297.12
3701/23/2024GUARDANT HEALTH INCGH40131M1090.50%398,076 (0) (0%)$9,243,324.72
3801/23/2024GOLDMAN FS TRSY OBLIG INST 468X9USDGSFT0.22%4,014,623 (-2,663,669) (-39.89%)$4,014,623.46
3901/23/2024INVITAE CORPNVTA46185L1030.21%8,950,816 (0) (0%)$3,832,739.41
4001/23/2024PFIZER INCPFE7170811030.19%126,752 (0) (0%)$3,588,349.12
4101/23/2024ABSCI CORPABSI00091E1090.09%461,717 (0) (0%)$1,669,106.96
4201/23/2024SENTI BIOSCIENCES INCSNTI81726A1000.04%1,780,618 (0) (0%)$751,242.73
4301/23/2024Senti Bio – place holdersharesDNBLFB2Y20.01%243,471 (0) (0%)$102,720.41
Source: https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_GENOMIC_REVOLUTION_ETF_ARKG_HOLDINGS.csv

Discover more from ARK Invest Daily Trades Tracker

Subscribe to get the latest posts sent to your email.

Leave a Comment